Nudelman Ronald K MD is categorized under Internal Medicine Doctors in Los Angeles, CA and active since 2006.
Nudelman Ronald K MD was established in 2006, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Ronald Nudelman at the company’s single location by writing to 11600 Wilshire Boulevard # 218, Los Angeles, California CA 90025 or by phoning (310) 312-2922. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Nudelman Ronald K MD |
| Contact Person: | Ronald Nudelman |
| Address: | 11600 Wilshire Boulevard # 218, Los Angeles, California 90025 |
| Phone Number: | (310) 312-2922 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2006 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Nudelman Ronald K MD was started in 2006 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Ronald Nudelman for inquiries that concern Nudelman Ronald K MD by calling the company number (310) 312-2922, as your correspondence is most welcome. Additionally, the physical location of the single location of Nudelman Ronald K MD can be found at the coordinates 34.053498,-118.45758 as well as the street address 11600 Wilshire Boulevard # 218 in Los Angeles, California 90025.
For its online presence, you may visit Nudelman Ronald K MD’s website at and engage with its social media outlets through on Twitter and on Facebook.